SYP and diabetes mellitus: This effect may be attributed to the inhibition of astrocyte activation, the reduction of hippocampal presynaptic vesicle protein synaptophysin (SYP), and the alleviation of neuroinflammation through the reduction of IL-1β and IL-6 levels in the brain of DM mice (71).